Literature DB >> 19519397

Tumor hypoxia as a modifier of DNA strand break and cross-link repair.

Norman Chan1, Cameron J Koch, Robert G Bristow.   

Abstract

Hypoxia is a common characteristic of many solid tumors and is associated with poor prognosis. Cells with low oxygen levels can have altered sensitivity to radiotherapy and chemotherapy secondary to changes in the incidence of DNA single- and double-strand breaks (DNA-ssb, DNA-dsb), DNA base damage, DNA-DNA cross-links and DNA-protein cross-links. Recent evidence also supports that cells exposed to chronic hypoxia have a decreased capacity of DNA-dsb repair. This review will examine the influence of short-term and prolonged hypoxia on the two major pathways of DNA-dsb repair: homologous recombination (HR) and non-homologous end-joining (NHEJ). Novel treatment strategies designed to exploit the hypoxic tumor microenvironment are also discussed. Modification of DNA damage sensing and repair due to fluctuating oxygen levels within a dynamic tumor microenvironment may have profound implications for tumor progression and treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19519397     DOI: 10.2174/156652409788167050

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  12 in total

Review 1.  The association between the rs11549465 polymorphism in the hif-1α gene and cancer risk: a meta-analysis.

Authors:  Yujie Li; Chunyan Li; Hui Shi; Lieming Lou; Pengcheng Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.

Authors:  Jeho Jeong; Jung Hun Oh; Jan-Jakob Sonke; Jose Belderbos; Jeffrey D Bradley; Andrew N Fontanella; Shyam S Rao; Joseph O Deasy
Journal:  Clin Cancer Res       Date:  2017-05-24       Impact factor: 12.531

Review 3.  Targeting hypoxia in cancer therapy.

Authors:  William R Wilson; Michael P Hay
Journal:  Nat Rev Cancer       Date:  2011-06       Impact factor: 60.716

Review 4.  Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy.

Authors:  Bassanelli Maria; Viterbo Antonella; Roberto Michela; Giacinti Silvana; Staddon Anita; Aschelter Anna Maria; D'Antonio Chiara; Marchetti Paolo
Journal:  Ther Adv Med Oncol       Date:  2016-07-25       Impact factor: 8.168

Review 5.  Unboxing the molecular modalities of mutagens in cancer.

Authors:  Smita Kumari; Sudhanshu Sharma; Dia Advani; Akanksha Khosla; Pravir Kumar; Rashmi K Ambasta
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-05       Impact factor: 5.190

6.  Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy-results from a prospective trial.

Authors:  Nils H Nicolay; Nicole Wiedenmann; Michael Mix; Wolfgang A Weber; Martin Werner; Anca L Grosu; Gian Kayser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-07       Impact factor: 9.236

7.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

Review 8.  Molecular culprits generating brain tumor stem cells.

Authors:  Se-Yeong Oh; Hyunggee Kim
Journal:  Brain Tumor Res Treat       Date:  2013-04-30

Review 9.  The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors.

Authors:  F Gizem Sonugür; Hakan Akbulut
Journal:  Front Genet       Date:  2019-10-29       Impact factor: 4.599

Review 10.  Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity.

Authors:  Luqing Zhao; Ann M Bode; Ya Cao; Zigang Dong
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.